NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $246,000 | -13.7% | 2,909 | -16.6% | 0.02% | -21.1% |
Q3 2021 | $285,000 | -8.1% | 3,487 | +2.6% | 0.02% | -9.5% |
Q2 2021 | $310,000 | +16.5% | 3,399 | +9.2% | 0.02% | +10.5% |
Q1 2021 | $266,000 | +13.2% | 3,113 | +25.0% | 0.02% | -9.5% |
Q4 2020 | $235,000 | +487.5% | 2,490 | +414.5% | 0.02% | +250.0% |
Q1 2020 | $40,000 | -13.0% | 484 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $46,000 | -47.7% | 484 | -52.0% | 0.01% | -53.8% |
Q3 2019 | $88,000 | +72.5% | 1,009 | +80.2% | 0.01% | +62.5% |
Q2 2019 | $51,000 | -5.6% | 560 | 0.0% | 0.01% | -11.1% |
Q1 2019 | $54,000 | +12.5% | 560 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $48,000 | -29.4% | 560 | -29.0% | 0.01% | -25.0% |
Q3 2018 | $68,000 | +13.3% | 789 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $60,000 | -6.2% | 789 | 0.0% | 0.01% | -14.3% |
Q1 2018 | $64,000 | -50.8% | 789 | -49.1% | 0.01% | -57.6% |
Q4 2017 | $130,000 | +22.6% | 1,551 | +25.5% | 0.03% | +6.5% |
Q3 2017 | $106,000 | – | 1,236 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |